GoAI
Get started
CellSource Co., Ltd. logo

CellSource Co., Ltd.

4880.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥337

−¥19.00 · -5.34%

Aug 24, 3:30 PM JST

4880.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP
CEO
Masayuki Yamakawa
Listed since
Oct 29, 2019
Employees
148

Market position

Day range

Current ¥337

52-week range

Current ¥337

Open
¥355
Previous close
¥356
Volume
59.5K
1.11× average
Average volume
53.7K
Average daily volume
Market cap
6.69B JPY
Beta
-0.09
Market reference 1
50-day average
¥323.56
+4.15% above average
200-day average
¥384.55
-12.36% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.35B JPY
P/E (TTM)
94.66×
P/B (TTM)
1.12×
P/S (TTM)
1.82×
EV / EBITDA
14.42×
Earnings yield
0.11%
Free cash flow yield
2.90%
Dividend yield
1.48%

Profitability & efficiency

Gross margin
57.57%
Operating margin
7.51%
Net margin
1.93%
Return on equity
0.18%
Return on assets
0.15%
Return on invested capital
0.24%

Financial health

Debt / equity
0×
Current ratio
12.39×
Altman Z-score
6.41
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends79%50%22%-7%Gross margin, FY2021: 70.58%Gross margin, FY2022: 71.39%Gross margin, FY2023: 70.05%Gross margin, FY2024: 54.25%Gross margin, FY2025: 56.24%Operating margin, FY2021: 33.99%Operating margin, FY2022: 36.76%Operating margin, FY2023: 27.08%Operating margin, FY2024: 2.97%Operating margin, FY2025: 4.49%Net margin, FY2021: 22.29%Net margin, FY2022: 23.82%Net margin, FY2023: 20.47%Net margin, FY2024: 5.46%Net margin, FY2025: 0.29%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 70.58%. Gross margin FY2022 71.39%. Gross margin FY2023 70.05%. Gross margin FY2024 54.25%. Gross margin FY2025 56.24%. Operating margin FY2021 33.99%. Operating margin FY2022 36.76%. Operating margin FY2023 27.08%. Operating margin FY2024 2.97%. Operating margin FY2025 4.49%. Net margin FY2021 22.29%. Net margin FY2022 23.82%. Net margin FY2023 20.47%. Net margin FY2024 5.46%. Net margin FY2025 0.29%.

Income trends

Revenue

3.71B JPY-14.78%

Operating income

166.71M JPY+29.07%

Net income

10.66M JPY-95.52%
Income trends across reported periods4.96B JPY3.16B JPY1.36B JPY−439.33M JPYRevenue, FY2021: 2.92B JPYRevenue, FY2022: 4.27B JPYRevenue, FY2023: 4.51B JPYRevenue, FY2024: 4.36B JPYRevenue, FY2025: 3.71B JPYOperating income, FY2021: 993.25M JPYOperating income, FY2022: 1.57B JPYOperating income, FY2023: 1.22B JPYOperating income, FY2024: 129.16M JPYOperating income, FY2025: 166.71M JPYNet income, FY2021: 651.4M JPYNet income, FY2022: 1.02B JPYNet income, FY2023: 923.14M JPYNet income, FY2024: 237.94M JPYNet income, FY2025: 10.66M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.92B JPY. Revenue FY2022 4.27B JPY. Revenue FY2023 4.51B JPY. Revenue FY2024 4.36B JPY. Revenue FY2025 3.71B JPY. Operating income FY2021 993.25M JPY. Operating income FY2022 1.57B JPY. Operating income FY2023 1.22B JPY. Operating income FY2024 129.16M JPY. Operating income FY2025 166.71M JPY. Net income FY2021 651.4M JPY. Net income FY2022 1.02B JPY. Net income FY2023 923.14M JPY. Net income FY2024 237.94M JPY. Net income FY2025 10.66M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue3.71B JPY4.36B JPY4.51B JPY4.27B JPY2.92B JPY
Cost of goods sold1.62B JPY1.99B JPY1.35B JPY1.22B JPY859.61M JPY
Gross profit2.09B JPY2.36B JPY3.16B JPY3.05B JPY2.06B JPY
Research and development19.07M JPY71.01M JPY72.45M JPY87.56M JPY71.16M JPY
Selling, general, and administrative1.9B JPY2.16B JPY1.87B JPY1.39B JPY998.22M JPY
Operating expenses1.92B JPY2.23B JPY1.94B JPY1.48B JPY1.07B JPY
Interest income251K JPY48K JPY13K JPY7K JPY2K JPY
Interest expense1.31M JPY1.36M JPY379K JPY11K JPY136K JPY
Depreciation and amortization204.32M JPY153.23M JPY66.38M JPY61.15M JPY54.26M JPY
Operating income166.71M JPY129.16M JPY1.22B JPY1.57B JPY993.25M JPY
Net income10.66M JPY237.94M JPY923.14M JPY1.02B JPY651.4M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
0.54
FY2025 · -95.48% year over year
Latest fiscal-year revenue
3.71B JPY
FY2025 · -14.78% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend58.2237.2516.27-4.7FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend4.67B4.03B3.4B2.76BFY21FY22FY23FY24FY25

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥5.00

2025 complete year-75.0% since 2023

Corporate action history

Dividend

Ex-dividend Oct 30, 2025

¥5.00

Annual

Record Oct 31, 2025 · Payment Jan 13, 2026

Dividend

Ex-dividend Oct 30, 2024

¥5.00

Annual

Record Oct 31, 2024 · Payment Jan 14, 2025

Dividend

Ex-dividend Oct 30, 2023

¥20.00

Annual

Record Oct 31, 2023 · Payment Jan 9, 2024

4880.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

ETFs holding 4880.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
8.15M
Weight
0.00%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥417.7-0.07%

Continue in GoAI

Research 4880.T

research.disclaimer